Adherium Ltd Total Liabilities
Adherium Ltd total liabilities. Based on the latest financial reports, Adherium Ltd (ADR) has total liabilities worth AU$4.94 Million AUD (≈ $3.50 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Adherium Ltd to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Adherium Ltd (2012–2025)
Total liabilities of Adherium Ltd from 2012 to 2025. This chart illustrates how Adherium Ltd's total liabilities have evolved over time, based on quarterly financial data.
Adherium Ltd Competitors by Total Liabilities
The table below lists competitors of Adherium Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Begbies Traynor Group PLC
LSE:BEG
|
UK | GBX83.60 Million |
|
Thai Setakij Insurance PCL
BK:TSI
|
Thailand | ฿949.34 Million |
|
Merko Gida Sanayi ve Ticaret AS
IS:MERKO
|
Turkey | TL953.48 Million |
|
MRG Metals Ltd
AU:MRQ
|
Australia | AU$182.35K |
|
Precomp Solutions AB Series B
ST:PCOM-B
|
Sweden | Skr72.30 Million |
|
Vast Renewables Limited Ordinary Shares
NASDAQ:VSTE
|
USA | $24.07 Million |
|
Planet Properindo Jaya Pt
JK:PLAN
|
Indonesia | Rp25.82 Billion |
|
Innovotech Inc
V:IOT
|
Canada | CA$993.81K |
Liability Composition Analysis (2012–2025)
This chart breaks down Adherium Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Adherium Ltd asset portfolio.
Liquidity & Leverage Metrics
Adherium Ltd Total Liabilities Ratios Explained
Adherium Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.13 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -6.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Adherium Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Adherium Ltd (2012–2025)
The table below shows the annual total liabilities of Adherium Ltd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$8.28 Million ≈ $5.86 Million |
+143.01% |
| 2024-06-30 | AU$3.41 Million ≈ $2.41 Million |
-1.74% |
| 2023-06-30 | AU$3.47 Million ≈ $2.45 Million |
+15.72% |
| 2022-06-30 | AU$3.00 Million ≈ $2.12 Million |
-0.27% |
| 2021-06-30 | AU$3.00 Million ≈ $2.13 Million |
-9.90% |
| 2020-06-30 | AU$3.33 Million ≈ $2.36 Million |
+135.79% |
| 2019-06-30 | AU$1.41 Million ≈ $1.00 Million |
-43.69% |
| 2018-06-30 | AU$2.51 Million ≈ $1.78 Million |
+5.24% |
| 2017-06-30 | AU$2.39 Million ≈ $1.69 Million |
+59.28% |
| 2016-06-30 | AU$1.50 Million ≈ $1.06 Million |
-42.93% |
| 2015-06-30 | AU$2.62 Million ≈ $1.86 Million |
+320.62% |
| 2014-06-30 | AU$624.09K ≈ $441.58K |
-6.43% |
| 2014-03-31 | AU$667.00K ≈ $471.94K |
+440.92% |
| 2013-06-30 | AU$123.31K ≈ $87.25K |
+18.57% |
| 2012-06-30 | AU$104.00K ≈ $73.59K |
-- |
About Adherium Ltd
Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides … Read more